Allogeneic bone marrow transplantation for hypereosinophilic syndrome: Long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript [5]

Bone Marrow Transplantation

Volumn 38, Issue 4, 2006, Pages 319-320

  Halaburda, K ^a   Prejzner, W ^a   Szatkowski, D ^a   Limon, J ^a   Hellmann, A ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; GANCICLOVIR; HYDROXYUREA; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; RIBAVIRIN; STEROID;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; AXILLARY LYMPH NODE; BRONCHOSPASM; CASE REPORT; CHROMOSOME ANALYSIS; ERADICATION THERAPY; FOLLOW UP; FUSION GENE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HEPATOSPLENOMEGALY; HUMAN; HYPEREOSINOPHILIC SYNDROME; LETTER; LEUKOCYTE COUNT; LONG TERM CARE; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; RNA ISOLATION; VALVULAR HEART DISEASE; VIRUS INFECTION;

ADULT; BONE MARROW TRANSPLANTATION; FOLLOW-UP STUDIES; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; ONCOGENE PROTEINS, FUSION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS;

EID: 33746967701     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705437     Document Type: Letter

References (8)

1. Gotlib J, Cools J, Malone III JM, Schrier SL, Gilliland DG, Coutre SE. The FIP1L1-PDGFRá fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: Implications for diagnosis, classification and management. Blood 2004; 103: 2879-2891.
2. Klion AD, Robyn J, Akin C, Noel P, Brown M, Law M et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 2004; 103: 473-478.
3. Schaller JL, Burkland GA. Case report: Rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. Med Gen Med 2001; 3: 9.
4. Archimbaud E, Guyotat D, Guillame C, Godard J, Fiere D. Hypereosinophilic syndrome with multiple organ dysfunction treated by allogeneic bone marrow transplantation. Am J Hematol 1988; 27: 302-303.
5. Juvonen E, Volin L, Koponen A, Ruutu T. Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome. Bone Marrow Transplant 2002; 29: 457-458.
6. Roche-Lestienne C, Lepers S, Soenen-Cornu V, Kahn JE, Lai JL, Hachulla E et al. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia 2005; 19: 792 798.
7. Tefferi A. Modern diagnosis and treatment of primary eosinophilia. Acta Haematol 2005; 114: 52-60.
8. Pardanani A, Brockman SR, Paternoster SF, Flynn HC, Ketterling RP, Lasho TL et al. FIP1L1-PDGFRA fusion: Prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 2004; 104: 3038-3045.